ORAL GENTAMICIN PREPARATION USING SOLIDIFIED LIPID PARTICULATE DELIVERY SYSTEM
Objective: Despite the broad pharmacological activity of gentamicin against a number of bacteria, it's very inadequate oral bioavailability due to poor intestinal membrane permeability has limited its formulation into oral dosage delivery system. This work was thus aimed at formulation and evaluation of gentamicin-loaded microemulsions based on preparation of lipid matrix for sustained release delivery.
Methods: Oral gentamicin suspensions were prepared by emulsification method using Tween 80 as a mobile surfactant in the lipid matrix dispersion. The resultant oral suspensions were evaluated for mean particle size and morphology using a photomicrograph, encapsulation efficiency/entrapment, EE (%), dispersibility, pH and absolute drug content. Release study as a function of inhibition zone diameter (IZD) and in vitro release study was also carried out. The in vitro release study was performed in both simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 7.2) respectively. The release data were analyzed mathematically according to zero order, first order and Higuchi equations.
Results: The prepared suspensions were cream-white in colour, easily dispersed and well homogenized. Batch D, which had least amount of excipients incorporated into the lipid matrix showed clumped irregular-shaped and less free-flowing particles. The particle size was significantly influenced by lipid matrix combination ratio in the presence of a surfactant (p<0.05). The mean particle size diameters of the samples were 15.44 mm, 10.64 mm, 4.12 mm, and 2.70 mm for batches A, B, C and D respectively. The values of EE obtained varied between 47% and 59% with Batch B exhibiting the highest value. The Higuchi model gave the best release kinetics result followed by zero order kinetics.
Conclusion: Oral gentamicin prepared exhibited antibacterial properties against Klebsiella spp., Escherchia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudomonas aeruginosa. The results suggest that a lipid matrix system could be useful as a sustained release oral delivery system of a poorly absorbable drug such as gentamicin.
2. Rama Prasad YV, Eaimtrakarn S, Ishida M, Kusawake Y, Tawa R, Yoshikawa Y, et al. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs. Int J Pharm 2003;11:13-21.
3. Robert MS, Walters KA. Dermal absorption and toxicity assessment. New York (USA): Marcel Dekker; 1998. p. 321-2.
4. Haswani DK, Nettey H, Oettinger C, D'Souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsul 2006;23:875-86.
5. Yamamoto CH, Pinto TJ. Rapid determination of neomycin by a microbiological agar diffusion assay using triphenyl tetrazolium chloride. J AOAC Int 1996;79:434-40.
6. Liang Y, Zhang T. Quantitative determination of streptomycin by first-derivative high-speed pulse polarography. Zhongguo Kangshengsu Zazhi 1991;16:102-5.
7. Yang CY, Zhang ZJ, Wang JL. New luminal chemiluminescence reaction using diperiodatoargentate as oxidate for the determination of amikacin sulphate. Luminescence 2010;25:36-42.
8. Huidobro AL, Garcia A, Barbas C. Rapid analytical procedure for neomycin determination in ointments by CE with direct UV detection. J Pharm Biomed Anal 2009;49:1303-7.
9. SÃ¡nchez-MartÃnez ML, Aguilar-Caballos MP, GÃ³mez-Hens A. Long wavelength homogeneous enzyme immunoassay for the determination of amikacin in water samples. Talanta 2009;78:305-9.
10. Kaya SE, Filazi A. Determination of antibiotic residues in milk samples. Kafkas Universitesi Veteriner Fakultesi Dergisi 2010;16:31-5.
11. Bohm DA, Stachel CS, Gowik P. Confirmatory method for the determination of streptomycin in apples by LC-MS/MS. Anal Chim Acta 2010;672:103-6.
12. El-Shabrawy Y. Fluorimetric determination of aminoglycoside antibiotics in pharmaceutical preparations and biological fluids. Spectrosc Lett 2002;35:99-109.
13. Al-Sabha TN. Spectrophotometric determination of amikacin sulphate via charge transfer complex formation reaction using tetracyanoethylene and 2,3-dichloro-5,6 dicyano-1,4-benzoquinone reagents. Arabian J Sci Eng 2010;35:27-40.
14. Omar MA, Nagy DM, Hammad MA, Aly AA. Validated spectrophotometric methods for determination of certain aminoglycosides in pharmaceutical formulations. J Appl Pharm Sci 2013;3:151-61.
15. Jia Y, Joly H, Omri A. Liposomes as a carrier for gentamicin delivery: development and evaluation of the physicochemical properties. Int J Pharm 2008;359:254-63.
16. Umeyor CE, Kenechukwu FC, Ogbonna JDN, Builders PF, Attama AA. Preliminary studies on the functional properties of gentamicin in SRMS-based solid lipid microparticles. Int J Drug Delivery Technol 2011;1:130-42.
17. Umeyor CE, Kenechukwu FC, Ogbonna JDN, Chime SA, Attama AA. Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo. J Microencapsul 2012;29:296-307.
18. Umeyor CE, Kenechukwu FC, Ogbonna JDN, Chime SA, Attama AA. Investigation of solidified reverse micellar systems as novel carriers for oral delivery of gentamicin. J Pharm Res 2014;5:4914-20.
19. Changez M, Burugapalli K, Koul V, Choudhary V. The effect of the composition of poly (acrylic acid)-gelatin hydrogel on gentamicin sulphate release: in vitro. Biomaterials 2003;24:527-36.
20. Eljarrat-Binstock E, Raiskup F, Stepensky D, Domb AJ, Frucht-Pery J. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis. Invest Ophthalmol Visual Sci 2004;103:1-12.
21. Nnamani PO, Kenechukwu FC, Dibua EU, Ogbonna CC, Monemeh UL, Attama AA. Transdermal microgels of gentamicin. Eur J Pharm Biopharm 2013;84:345-54.
22. Ahangari A, Salouti M, Heidari Z, Kazemizadeh AR, Safari AA. Development of gentamicin-gold nano spheres for antimicrobial drug delivery to staphylococcal infected foci. Drug Delivery 2013;20:34-9.
23. Sarabia-Sainz A, Montfort GR, Lizardi-Mendoza J, SÃ¡nchez-Saavedra MP, Candia-Plata MC, Guzman RZ, et al. Formulation and characterization of gentamicin-loaded albumin microspheres as a potential drug carrier for the treatment of E. coli K88 infections. Int J Drug Delivery 2012;4:209-18.
24. Momoh MA, Esimone CO. Phospholipon 90H (P90H)-based PEGylated microscopic lipospheres delivery system for gentamicin: an antibiotic evaluation. Asian Pacific J Trop Biomed 2012;2:889-94.
25. Al-Tahami K. Preparation, characterization, and in vitro release of ketoprofen loaded alginate microspheres. Int J Appl Pharm 2014;6:9-12.
26. Abraham S, Abhilash TV, Jacob L. Formulation and evaluation of perindopril microcapsules using different polymer. Asian J Pharm Clin Res 2017;10:153-6.
27. Kalita B, Saikia K, Kalita B. Development and characterization of the mucoadhesive microsphere-loaded intranasal gel of venlafaxine hydrochloride. Asian J Pharm Clin Res 2016;9:139-44.
28. Deshmukh MT, Mohite SK. Formulation and characterization of olanzapine-loaded mucoadhesive microspheres. Asian J Pharm Clin Res 2017;10:249-55.
29. Adikwu MU, Nnamani PO, Attama AA. Evaluation of snail mucin as bioadhesive agent for the delivery of chlorpropamide. Biol Res 2005;3:75-85.
30. Mohite PB, Khanage SG, Harishchandre VS, Shirsath Y. Recent advances in micro sponges drug delivery system. J Crit Rev 2016;3:9-16.
31. Kenechukwu FC, Umeyor CE, Momoh MA, Ogbonna JDN, Chime SA, Nnamani PO, et al. Evaluation of gentamicin-entrapped solid lipid microparticles formulated with a biodegradable homolipid from Capra hircus. Trop J Pharm Res 2014;13:1199-205.
32. Attama AA, Okafor CE, Builders PF, Okorie O. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. Drug Delivery 2009;16:448-57.
33. Fana Y, Lia X, Zhoua Y, Fana C, Wanga X, Huangb Y, et al. Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions. Int J Pharm 2011;416:323-30.
34. Hanh ND, A Mitrevej, Sathirakul K, Peungvicha P, Sinchaipanid N. Development of phyllanthin-loaded self-micro emulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm 2015;41:207-17.
35. Kollipara S, Gandhi RK. Pharmacokinetic aspects and in vitroâ€“in vivo correlation potential for lipid-based formulations. Acta Pharm Sinica B 2014;4:333-49.